Medigen Biotechnology Corporation
Clinical trials sponsored by Medigen Biotechnology Corporation, explained in plain language.
-
Donor immune cells tested to stop deadly cancers from returning
Disease control Recruiting nowThis study is testing whether adding donor immune cells (called NK cells) to standard chemotherapy helps prevent cancer from coming back after surgery. It will involve about 42 adults with pancreatic or bile duct cancer who have had their tumor surgically removed. The research fi…
Phase: PHASE1, PHASE2 • Sponsor: Medigen Biotechnology Corporation • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
First human test: can supercharged immune cells stop colon Cancer's return?
Disease control Recruiting nowThis is an early safety study for a new personalized cell therapy called Magicell-NK. It aims to find a safe dose of these specially grown immune cells for patients with early-stage colon cancer who have already had their tumor surgically removed. Researchers will give the therap…
Phase: PHASE1 • Sponsor: Medigen Biotechnology Corporation • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC